Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis

Cellular Immunology

Volumn 265, Issue 2, 2010, Pages 105-110

  Deng, Shaohua ^a   Xi, Yebin ^a   Wang, Hong ^a   Hao, Jing ^a   Niu, Xiaoyin ^a   Li, Weiyi ^a   Tao, Yue ^b   Chen, Guangjie ^a  

^a Shanghai Institute of Immunology   (China)

^b Guanghua Rheumatology Hospital   (China)

Author keywords

Autoimmune disease; CD4+ CD25+ regulatory T cells (Tregs); Collagen induced arthritis (CIA); Th17; Vasoactive intestinal peptide (VIP)

Indexed keywords

COLLAGEN; COLLAGEN TYPE 2; FREUND ADJUVANT; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INCIDENCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD24; ARTHRITIS, EXPERIMENTAL; DOWN-REGULATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; OSTEOPROTEGERIN; RANK LIGAND; RATS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; VASOACTIVE INTESTINAL PEPTIDE;

RATTUS; RATTUS NORVEGICUS;

EID: 77957021157     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.07.010     Document Type: Article

References (33)

1. Goronzy J.J., Weyand C.M. Rheumatoid arthritis. Immunol. Rev. 2005, 204:55-73.
2. Kotake S., Udagawa N., Hakoda M., Mogi M., Yano K., Tsuda E., Takahashi K., Furuya T., Ishiyama S., Kim K.J., Saito S., Nishikawa T., Takahashi N., Togari A., Tomatsu T., Suda T., Kamatani N. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis. Rheum. 2001, 44:1003-1012.
3. Husby G., Williams R.C. Immunohistochemical studies of interleukin-2 and gamma-interferon in rheumatoid arthritis. Arthritis. Rheum. 1985, 28:174-181.
4. Chu C.Q., Song Z., Mayton L., Wu B., Wooley P.H. IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. Ann. Rheum. Dis. 2003, 62:983-990.
5. Irmler I.M., Gajda M., Brauer R. Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J. Immunol. 2007, 179:6228-6236.
6. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
7. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
8. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 2007, 7:292-304.
9. Wong C.K., Lit L.C., Tam L.S., Li E.K., Wong P.T., Lam C.W. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin. Immunol. 2008, 127:385-393.
10. Hedegaard C.J., Krakauer M., Bendtzen K., Lund H., Sellebjerg F., Nielsen C.H. T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis. Immunology 2008, 125:161-169.
11. Chabaud M., Durand J.M., Buchs N., Fossiez F., Page G., Frappart L., Miossec P. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis. Rheum. 1999, 42:963-970.
12. Koenders M.I., Devesa I., Marijnissen R.J., Abdollahi-Roodsaz S., Boots A.M., Walgreen B., di Padova F.E., Nicklin M.J., Joosten L.A., van den Berg W.B. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice. Arthritis. Rheum. 2008, 58:3461-3470.
13. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., Cua D.J., Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 2006, 203:2673-2682.
14. Tang Q., Bluestone J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 2008, 9:239-244.
15. Ehrenstein M.R., Evans J.G., Singh A., Moore S., Warnes G., Isenberg D.A., Mauri C. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 2004, 200:277-285.
16. Hernanz A., Tato E., De la Fuente M., de Miguel E., Arnalich F. Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by whole blood cells from healthy young and old subjects. J. Neuroimmunol. 1996, 71:25-30.
17. Pozo D., Gonzalez-Rey E., Chorny A., Anderson P., Varela N., Delgado M. Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders. Peptides 2007, 28:1833-1846.
18. + regulatory T cells in vivo: therapeutic applications in autoimmunity and transplantation. Ann. NY Acad. Sci. 2006, 1070:190-195.
19. Fernandez-Martin A., Gonzalez-Rey E., Chorny A., Ganea D., Delgado M. Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2006, 36:318-326.
20. Delgado M., Abad C., Martinez C., Leceta J., Gomariz R.P. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med. 2001, 7:563-568.
21. + T cells and the control of autoimmune disease. Curr. Opin. Immunol. 2004, 16:695-701.
22. Wei L., Laurence A., Elias K.M., O'Shea J.J. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 2007, 282:34605-34610.
23. Ivanov, McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
24. Taylor P.C., Peters A.M., Paleolog E., Chapman P.T., Elliott M.J., McCloskey R., Feldmann M., Maini R.N. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis. Rheum. 2000, 43:38-47.
25. Takayanagi H., Iizuka H., Juji T., Nakagawa T., Yamamoto A., Miyazaki T., Koshihara Y., Oda H., Nakamura K., Tanaka S. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis. Rheum. 2000, 43:259-269.
26. + T regulatory cells with therapeutic effect in collagen-induced arthritis. Arthritis. Rheum. 2006, 54:864-876.
27. Lubberts E., Joosten L.A., Oppers B., van den Bersselaar L., Coenen-de Roo C.J., Kolls J.K., Schwarzenberger P., van de Loo F.A., van den Berg W.B. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J. Immunol. 2001, 167:1004-1013.
28. Yadav M., Rosenbaum J., Goetzl E.J. Cutting edge: vasoactive intestinal peptide (VIP) induces differentiation of Th17 cells with a distinctive cytokine profile. J. Immunol. 2008, 180:2772-2776.
29. Yadav M., Goetzl E.J. Vasoactive intestinal peptide-mediated Th17 differentiation: an expanding spectrum of vasoactive intestinal peptide effects in immunity and autoimmunity. Ann. NY Acad. Sci. 2008, 1144:83-89.
30. Delgado M. VIP: a very important peptide in T helper differentiation. Trends. Immunol. 2003, 24:221-224.
31. Zhou L., Lopes J.E., Chong M.M., Ivanov, Min R., Victora G.D., Shen Y., Du J., Rubtsov Y.P., Rudensky A.Y., Ziegler S.F., Littman D.R. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
32. Horwood N.J., Kartsogiannis V., Quinn J.M., Romas E., Martin T.J., Gillespie M.T. Activated T lymphocytes support osteoclast formation in vitro. Biochem. Biophys. Res. Commun. 1999, 265:144-150.
33. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., Saito S., Inoue K., Kamatani N., Gillespie M.T., Martin T.J., Suda T. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 1999, 103:1345-1352.